Recent Finacing
Recent Raise
Arch Oncology is a clinical immuno-oncology company developing anti-CD47 biologics, advancing AO-176 in Phase 1/2 trials and discovery-stage anti-SIRP programs from offices in Brisbane, CA and St. Louis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Arch Oncology.
